ALAB heads into its August 4 earnings report with a sharp, awkward gap between where the stock is trading and where analysts think it should be — and with options traders growing visibly more cautious after a brutal session.
Thursday's 10.8% drop pulled the stock to $291.58, down 27% on the month and now sitting roughly 35% below the consensus analyst price target of $297. That target figure is itself interesting: it reflects the most conservative end of a recent wave of upgrades. Barclays lifted its target to $325 on July 20. TD Cowen moved to $425 on July 13. UBS raised to $400 at the end of June. Stifel and BofA Securities both increased their targets to $460 and $450 respectively in late June. None of these firms changed their ratings — all are either Neutral, Hold, or Buy — which creates an unusual picture where even the neutral-to-bearish analysts now sit well above the current price. The stock has simply fallen faster than targets have chased it down.
Options positioning picked up in line with the selloff, turning more defensive than it has been in weeks. The put/call ratio reached 0.84 on Friday, running close to 1.7 standard deviations above its 20-day mean of 0.81. That is not yet at the 52-week high of 1.03, but the direction is clear: demand for downside protection has risen sharply as the print approaches. Short interest is a secondary story here. At 6.7% of free float — roughly 11.4 million shares — it is elevated but has been declining steadily from a peak near 13.2 million shares in late June. The borrow market is loose, with availability far exceeding what would be needed for any squeeze dynamic, and cost to borrow remains low at 0.56%. The lending market is not adding pressure to this situation.
The Street debate is captured cleanly in the bull and bear cases. Bulls point to the Scorpio product ramp and a new custom Leo CXL controller win at a leading hyperscaler — specific, tangible catalysts that tie ALAB's growth to AI infrastructure build-outs where capex remains robust. Bears focus on the operating margin trajectory: rising taxes, increasing competition from larger players entering the connectivity space, and questions about whether current gross margins can hold through a technology transition cycle. Valuation remains the persistent bear argument. The P/E multiple stands near 85x and has compressed 26 points over the past 30 days — the market has already repriced some of the growth premium, but the EV/EBITDA above 72x still leaves little room for any execution miss. EPS momentum scores rank in the 82nd percentile over 30 days, suggesting the estimate revision cycle has been supportive. But the forward EPS growth rank sits in just the 11th percentile, flagging that the consensus already prices in meaningful deceleration.
The insider picture adds a layer worth noting. Chairman Manuel Alba-Marquez sold approximately $15.8 million in shares on July 1 across multiple tranches, at prices in the $429–$450 range — well above where the stock now trades. The sales appear to have been planned disposals rather than a directional signal, but the timing is notable given the subsequent 35% decline in the price. Net insider activity on a 90-day basis is a small positive in share count terms, though the headline dollar figure reflects the heavy selling at prior highs.
Earnings reactions have been mixed. The May 2026 print sent the stock down 9.3% on the day before recovering 3.9% over the following week. The prior print produced a 6.3% gain. The August 4 release will be the sharper test: the stock enters it down 27% from its recent peak, with analyst targets implying meaningful recovery potential but options traders actively hedging against further downside. What to watch is whether the Scorpio ramp cadence and any update on the hyperscaler CXL design win provide enough concrete evidence to close the gap between where the stock is and where even the most cautious analysts on the Street believe it belongs.
See the live data behind this article on ORTEX.
Open ALAB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
